A Double Blind Placebo Controlled Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian Tubal or Peritoneal Origin

  • Modesitt, Susan (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/8/036/30/04